{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:41:42Z","timestamp":1782859302351,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","award":["11511"],"award-info":[{"award-number":["11511"]}],"id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.MAZUMS.REC.1400.640"],"award-info":[{"award-number":["IR.MAZUMS.REC.1400.640"]}],"id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ijantimicag.2023.106715","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T20:49:02Z","timestamp":1673470142000},"page":"106715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antifungal activity of miltefosine against both azole-susceptible and -resistant Aspergillus strains"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9723-7618","authenticated-orcid":false,"given":"Iman","family":"Haghani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Yahyazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Taghi","family":"Hedayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3094-8436","authenticated-orcid":false,"given":"Tahereh","family":"Shokohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Badali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1151-9265","authenticated-orcid":false,"given":"Shaghayegh","family":"Khojasteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9040-0267","authenticated-orcid":false,"given":"Javad","family":"Akhtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9336-2518","authenticated-orcid":false,"given":"Javad","family":"Javidnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Moazeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Al-Harrasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Reza","family":"Aghili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firoozeh","family":"Kermani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Hajheydari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah M.S.","family":"Al Hatmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0016-2849","authenticated-orcid":false,"given":"Mahdi","family":"Abastabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2023.106715_bib0001","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/jac\/dky517","article-title":"Emerging threat of triazole-resistant Aspergillus fumigatus","volume":"74","author":"Rybak","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106715_bib0002","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s40506-014-0016-2","article-title":"Treatment options in invasive aspergillosis","volume":"6","author":"Panackal","year":"2014","journal-title":"Curr Treat Opt Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106715_bib0003","doi-asserted-by":"crossref","first-page":"e01458","DOI":"10.1128\/mBio.01458-21","article-title":"Screening of chemical libraries for new antifungal drugs against Aspergillus fumigatus reveals sphingolipids are involved in the mechanism of action of miltefosine","volume":"12","author":"dos Reis","year":"2021","journal-title":"Mbio"},{"key":"10.1016\/j.ijantimicag.2023.106715_bib0004","doi-asserted-by":"crossref","first-page":"6996","DOI":"10.1128\/AAC.03212-14","article-title":"In vitro combination of voriconazole and miltefosine against clinically relevant molds","volume":"58","author":"Imbert","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106715_bib0005","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1093\/jac\/dkt282","article-title":"In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens","volume":"68","author":"Biswas","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106715_bib0006","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s40262-017-0570-0","article-title":"Clinical pharmacokinetics of systemically administered antileishmanial drugs","volume":"57","author":"Kip","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2023.106715_bib0007","doi-asserted-by":"crossref","first-page":"e02063","DOI":"10.1128\/AAC.02063-19","article-title":"In vitro antifungal susceptibility of the emerging multidrug-resistant pathogen Candida auris to miltefosine alone and in combination with amphotericin B","volume":"64","author":"Wu","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106715_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106049","article-title":"Miltefosine as an alternative strategy in the treatment of the emerging fungus Candida auris","volume":"56","author":"Barreto","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2023.106715_bib0009","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts, approved standard. CLSI document M27-A2","year":"2002"},{"key":"10.1016\/j.ijantimicag.2023.106715_bib0010","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1128\/AAC.50.2.414-421.2006","article-title":"Hexadecylphosphocholine (miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis","volume":"50","author":"Widmer","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106715_bib0011","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.1128\/AAC.01193-16","article-title":"Potent activities of novel imidazoles lanoconazole and luliconazole against a collection of azole-resistant and-susceptible Aspergillus fumigatus strains","volume":"60","author":"Abastabar","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106715_bib0012","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1099\/jmm.0.000255","article-title":"High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?","volume":"65","author":"Nabili","year":"2016","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106715_bib0013","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3201\/eid1710.110226","article-title":"Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007\u20132009","volume":"17","author":"van der Linden","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106715_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.698662","article-title":"Miltefosine against Scedosporium and Lomentospora species: antifungal activity and its effects on fungal cells","volume":"11","author":"Rollin-Pinheiro","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijantimicag.2023.106715_bib0015","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1016\/j.bmcl.2013.06.096","article-title":"Synthesis and antifungal activities of miltefosine analogs","volume":"23","author":"Ravu","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2023.106715_bib0016","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1128\/AAC.01624-12","article-title":"Limited activity of miltefosine in murine models of cryptococcal meningoencephalitis and disseminated cryptococcosis","volume":"57","author":"Wiederhold","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2023.106715_bib0017","article-title":"Acute uveitis: a rare adverse effect of miltefosine in the treatment of post-kala-azar dermal leishmaniasis","volume":"53","author":"Pandey","year":"2020","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.ijantimicag.2023.106715_bib0018","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","article-title":"Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World","volume":"118","author":"Oliveira","year":"2011","journal-title":"Acta Trop"},{"key":"10.1016\/j.ijantimicag.2023.106715_bib0019","article-title":"Neurologic adverse events associated with voriconazole therapy: report of two pediatric cases","volume":"2016","author":"Demir","year":"2016","journal-title":"Case Rep Infect Dis"},{"key":"10.1016\/j.ijantimicag.2023.106715_bib0020","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/AAC.00014-08","article-title":"Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients","volume":"52","author":"Dorlo","year":"2008","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923000079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857923000079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:12:02Z","timestamp":1777583522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857923000079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0924857923000079"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106715","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifungal activity of miltefosine against both azole-susceptible and -resistant Aspergillus strains","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106715","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106715"}}